This funding opportunity supports the development and application of human microphysiologic systems (MPS) to study infectious diseases and develop therapeutics or biological products. It encourages projects that advance MPS adoption by drug developers and regulatory agencies, aiming to reduce animal use and improve human tissue modeling for infectious disease research and product development.
Eligible applicants include a wide range of U.S. government entities, educational institutions, nonprofits, for-profit organizations, tribal governments, and foreign institutions. Specific eligibility details are extensive and diverse.
